DOTAP Cholesterol-Fus1 liposome

Cholesterol-Fus1 liposome formulated with DOTAP · M.D. Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DOTAP Cholesterol-Fus1 liposome, covering 2012-02-23 to 2012-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer [Phase 1]